人工智能干预临床试验报告指南:CONSORT-AI扩展
CONSORT-AI是评估含人工智能(AI)干预的临床试验的新报告指南,与SPIRIT-AI并行制定。通过文献综述、两阶段Delphi调查(103名利益相关者)、共识会议(31名利益相关者)和清单试点(34名参与者)形成。该扩展包含14个新条目,建议常规报告AI干预的清晰描述、使用说明和技能要求、整合环境、输入输出处理、人机交互及错误案例分析。
要点
- CONSORT-AI扩展包含14个新条目,应常规报告于AI干预临床试验。
- 需清晰描述AI干预、使用说明和技能、整合环境、输入输出处理。
- 应报告人机交互并提供错误案例分析。
核心结论
- CONSORT-AI有助于促进AI干预临床试验报告的透明性和完整性。
- 该指南帮助编辑、同行审稿人和读者理解、解释和批判性评估试验设计质量和报告结局的偏倚风险。
研究设计与样本
- 通过分阶段共识过程制定,包括文献综述和专家咨询生成29个候选条目。
- 国际多利益相关者小组进行两阶段Delphi调查(103名利益相关者)。
- 为期两天的共识会议(31名利益相关者)达成一致,并通过清单试点(34名参与者)完善。
主要发现
- CONSORT-AI扩展包括14个新条目,被认为对AI干预足够重要,应常规报告于核心CONSORT 2010条目之外。
关键数值与推荐
- CONSORT-AI建议研究者提供AI干预的清晰描述,包括使用说明和所需技能。
- 建议报告AI干预整合的环境。
- 建议报告AI干预输入和输出的处理。
- 建议报告人机交互并提供错误案例分析。
临床怎么用
- 研究者应在AI干预临床试验报告中常规使用CONSORT-AI扩展的14个新条目。
- 编辑和同行审稿人可使用该指南评估AI干预临床试验报告的质量和偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The CONSORT 2010 statement provides minimum guidelines for reporting randomized trials. Its widespread use has been instrumental in ensuring transparency in the evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate impact on health outcomes. The CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) extension is a new reporting guideline for clinical trials evaluating interventions with an AI component. It was developed in parallel with its companion statement for clinical trial protocols: SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 29 candidate items, which were assessed by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a two-day consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The CONSORT-AI extension includes 14 new items that were considered sufficiently important for AI interventions that they should be routinely reported in addition to the core CONSORT 2010 items. CONSORT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention is integrated, the handling of inputs and outputs of the AI intervention, the human-AI interaction and provision of an analysis of error cases. CONSORT-AI will help promote transparency and completeness in reporting clinical trials for AI interventions. It will assist editors and peer reviewers, as well as the general readership, to understand, interpret and critically appraise the quality of clinical trial design and risk of bias in the reported outcomes.
引用
- Liu X, Cruz Rivera S, Moher D, et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat Med. 2020. PMID: 32908283. doi:10.1038/s41591-020-1034-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。